Nuveen Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $43.4M | Buy |
529,650
+65,713
| +14% | +$5.38M | 0.01% | 712 |
|
|
2024
Q3 | $53M | Buy |
463,937
+138,776
| +43% | +$15.9M | 0.01% | 629 |
|
|
2024
Q2 | $24.6M | Buy |
325,161
+13,809
| +4% | +$1.04M | 0.01% | 1004 |
|
|
2024
Q1 | $21.3M | Buy |
311,352
+30,496
| +11% | +$2.08M | 0.01% | 1142 |
|
|
2023
Q4 | $17.6M | Sell |
280,856
-15,556
| -5% | -$977K | 0.01% | 1239 |
|
|
2023
Q3 | $15.1M | Buy |
296,412
+2,506
| +0.9% | +$128K | 0.01% | 1219 |
|
|
2023
Q2 | $14.7M | Buy |
293,906
+34,688
| +13% | +$1.73M | 0.01% | 1275 |
|
|
2023
Q1 | $9.72M | Buy |
259,218
+2,842
| +1% | +$107K | ﹤0.01% | 1501 |
|
|
2022
Q4 | $12.3M | Buy |
256,376
+66,864
| +35% | +$3.21M | ﹤0.01% | 1358 |
|
|
2022
Q3 | $4.55M | Buy |
189,512
+37,353
| +25% | +$896K | ﹤0.01% | 1960 |
|
|
2022
Q2 | $3.31M | Buy |
152,159
+11,333
| +8% | +$247K | ﹤0.01% | 2180 |
|
|
2022
Q1 | $3.48M | Sell |
140,826
-1,518
| -1% | -$37.5K | ﹤0.01% | 2254 |
|
|
2021
Q4 | $2.99M | Sell |
142,344
-10,637
| -7% | -$224K | ﹤0.01% | 2369 |
|
|
2021
Q3 | $3.88M | Sell |
152,981
-7,855
| -5% | -$199K | ﹤0.01% | 2346 |
|
|
2021
Q2 | $3.62M | Buy |
160,836
+65,143
| +68% | +$1.47M | ﹤0.01% | 2408 |
|
|
2021
Q1 | $1.89M | Buy |
95,693
+22,992
| +32% | +$454K | ﹤0.01% | 2645 |
|
|
2020
Q4 | $1.93M | Sell |
72,701
-4,958
| -6% | -$132K | ﹤0.01% | 2528 |
|
|
2020
Q3 | $3.84M | Buy |
+77,659
| New | +$3.84M | ﹤0.01% | 2058 |
|